Found 23 matching trials
Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa Study PHASE2 This study is being carried out to see if ZD1839 is effective in treating m...
Show More Learn More & Join Trial
Assess the Efficacy, Safety and Tolerability of Gefitinib (Iressa® 250mg) as Maintenance Therapy in Locally Advanced or Metastatic (Stage IIIB/IV) Non Small Cell Lung Cancer (NSCLC) PHASE4 This is a double blind, multicentre, randomized, placebo-controlled study. ...
Show More Learn More & Join Trial
Clinical Study of Chinese Medicine Plus Targeted Therapy Maintenance in Advanced Pulmonary Adenocarcinoma PHASE3 The investigators performed a randomized, double blind controlled, prospect...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of BPI-7711 Capsule in Non-small Cell Lung Cancer Patients PHASE3 A randomized, double-blind, positive controlled phase III study to evaluate...
Show More Status
Active Not Recruiting
Location
Cancer Hospital Chinese Academy of Medical Sciences
Learn More & Join Trial
Gefitinib With or Without Tamoxifen in Treating Patients With Tamoxifen-Resistant Metastatic Breast Cancer PHASE2 RATIONALE: Gefitinib may stop the growth of tumor cells by blocking the enz...
Show More Location
Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center
Learn More & Join Trial
A Study of IRESSA Treatment Beyond Progression in Addition to Chemotherapy Versus Chemotherapy Alone PHASE3 The purpose of this study is to assess the efficacy and safety of gefitinib...
Show More Learn More & Join Trial
ASK120067 Versus Gefitinib as First-line Treatment for EGFRm Locally Advanced or Metastatic NSCLC PHASE3 To assess the efficacy and safety of ASK120067 versus a standard of care ep...
Show More Status
Active Not Recruiting
Location
Chinese Academy of Medical Sciences
Learn More & Join Trial
Alflutinib Mesylate Versus Gefitinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (FLAG) PHASE3 To assess the efficacy and safety of Alflutinib Mesylate versus Gefitinib i...
Show More Status
Active Not Recruiting
Location
cancer hospital Chinese academy of medical sciences
Learn More & Join Trial
Phase III Trial Of Docetaxel Versus Docetaxel Plus ZD1839 In Head And Neck Cancer PHASE3 Drugs used in chemotherapy, such as docetaxel, work in different ways to st...
Show More Location
Eastern Cooperative Oncology Group
Learn More & Join Trial
IRESSA™ (Gefitinib) With Cisplatin Plus Radiotherapy for the Treatment of Previously Untreated Unresected Late Stage III/IV Non-Metastatic Head and Neck Squamous Cell Carcinoma PHASE2 The primary purpose of this study is to assess the effectiveness of ZD1839 ...
Show More Learn More & Join Trial